標(biāo)題: Titlebook: Gene Therapy of Autoimmune Disease; Gérald J. Prud’homme Book 2005 Springer-Verlag US 2005 Antigen.DNA.autoimmune disease.gene therapy.gen [打印本頁(yè)] 作者: CK828 時(shí)間: 2025-3-21 19:52
書目名稱Gene Therapy of Autoimmune Disease影響因子(影響力)
書目名稱Gene Therapy of Autoimmune Disease影響因子(影響力)學(xué)科排名
書目名稱Gene Therapy of Autoimmune Disease網(wǎng)絡(luò)公開度
書目名稱Gene Therapy of Autoimmune Disease網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Gene Therapy of Autoimmune Disease被引頻次
書目名稱Gene Therapy of Autoimmune Disease被引頻次學(xué)科排名
書目名稱Gene Therapy of Autoimmune Disease年度引用
書目名稱Gene Therapy of Autoimmune Disease年度引用學(xué)科排名
書目名稱Gene Therapy of Autoimmune Disease讀者反饋
書目名稱Gene Therapy of Autoimmune Disease讀者反饋學(xué)科排名
作者: 拍下盜公款 時(shí)間: 2025-3-22 00:07 作者: cathartic 時(shí)間: 2025-3-22 02:45 作者: 使長(zhǎng)胖 時(shí)間: 2025-3-22 06:46 作者: FLIT 時(shí)間: 2025-3-22 11:40
Laura M. Cersosimo,André-Denis G. Wrightbitors such as IL-1 receptor antagonist (IL-lRa), soluble interferon gamma (IFNβ) receptor (IFNβR)/IgG-Fc fusion protein, or TNFα receptor (TNFR). Furthermore, in vivo transfer of nucleic acid segments (or plasmid-based delivery of these molecules), such as cytosine-phosphate-guanine (CpG)-containin作者: 搜集 時(shí)間: 2025-3-22 13:42
Gérald J. Prud’hommeUp to date comprehensive work.The only volume of its kind to cover gene therapy for autoimmune diseases.Includes supplementary material: 作者: 搜集 時(shí)間: 2025-3-22 18:55 作者: 同時(shí)發(fā)生 時(shí)間: 2025-3-22 21:20
https://doi.org/10.1007/978-3-030-78746-2ases lacking a definitive cure and with a devastating social impact. However, there are still several issues to solve before these approaches would be transferable to humans..Some studies are conceptually non applicable to human diseases. For instance, T and B cell-based antigen-specific approaches 作者: 暫時(shí)別動(dòng) 時(shí)間: 2025-3-23 04:35
M. M. Deshmukh,Ahmed Elbeltagi,Saber Kouadrin output, diabetes mellitus will continue to be a challenging disorder in which these agents could be applied. Gene therapeutics, however, will take advantage of the knowledge of the underlying stage and severity of diabetes and will very likely be patient-specific. Nonetheless, a targeted approach,作者: 觀察 時(shí)間: 2025-3-23 06:57 作者: Calibrate 時(shí)間: 2025-3-23 10:04 作者: 不透明 時(shí)間: 2025-3-23 14:57
Global Framework on Climate Changeents in the future. Gene therapy approaches, when introduced, do not imply the exclusion of former therapies. They are only specific and promising examples of targeted therapies that are not based on the use of protein anymore, but rather on a gene encoding this protein. In the future, we will try t作者: 巧辦法 時(shí)間: 2025-3-23 21:24 作者: Ebct207 時(shí)間: 2025-3-24 01:31
Effects of Climate Change on Vegetation,ttenuation of pathogenic immune responses is a highly desirable end. Many forms of immunotherapy are being studied with these objectives in mind, but gene transfer approaches, and particularly DNA vaccination (transfer of an antigen gene), are promising. DNA vaccination is most often performed by no作者: Creditee 時(shí)間: 2025-3-24 02:42 作者: 樂章 時(shí)間: 2025-3-24 10:19
toimmune diseases are diverse and responsible for considerable morbidity. Their etiology remains largely unknown, and current therapy with anti-inflammatory drugs is prone to adverse effects, and rarely curative. New therapies with anti-cytokine antibodies or receptors are promising, but require fre作者: BYRE 時(shí)間: 2025-3-24 13:38 作者: 獸皮 時(shí)間: 2025-3-24 16:50 作者: 失誤 時(shí)間: 2025-3-24 22:10
https://doi.org/10.1007/1-4020-3876-3hey relate to the treatment of autoimmune disease in experimental animal models will be the focus of this chapter, with particular emphasis on the analogs of multiple sclerosis (MS), insulin-dependent diabetes mellitus (IDDM) and rheumatoid arthritis (RA).作者: persistence 時(shí)間: 2025-3-24 23:14 作者: 莎草 時(shí)間: 2025-3-25 04:58
Targeting Antigen-Specific T Cells for Gene Therapy of Autoimmune Disease,hey relate to the treatment of autoimmune disease in experimental animal models will be the focus of this chapter, with particular emphasis on the analogs of multiple sclerosis (MS), insulin-dependent diabetes mellitus (IDDM) and rheumatoid arthritis (RA).作者: Notorious 時(shí)間: 2025-3-25 08:51 作者: STING 時(shí)間: 2025-3-25 12:49 作者: transdermal 時(shí)間: 2025-3-25 16:47 作者: defendant 時(shí)間: 2025-3-25 21:37
M. A. Munoz,Angel Faz,Ahmet R. Mermut proteins. This deregulation will eventually lead to a systemic disease manifested by organ or tissue specific disorder and pathogenesis. Reversal of this breakdown by the re-introduction of tolerance is therefore an important goal.作者: Rustproof 時(shí)間: 2025-3-26 02:19 作者: 拋媚眼 時(shí)間: 2025-3-26 06:29 作者: savage 時(shí)間: 2025-3-26 11:32 作者: Interregnum 時(shí)間: 2025-3-26 15:02
Gene Therapy Approaches for Autoimmune Diseases of the Central Nervous System and Other Tissues,ases lacking a definitive cure and with a devastating social impact. However, there are still several issues to solve before these approaches would be transferable to humans..Some studies are conceptually non applicable to human diseases. For instance, T and B cell-based antigen-specific approaches 作者: installment 時(shí)間: 2025-3-26 17:11 作者: NUL 時(shí)間: 2025-3-27 00:33 作者: 概觀 時(shí)間: 2025-3-27 01:32 作者: enchant 時(shí)間: 2025-3-27 06:55 作者: 貧困 時(shí)間: 2025-3-27 13:02
Gene Therapy-Based Approach for Immune Tolerance Induction Using Recombinant Immunoglobulin Carrierne diseases. Tolerance to “self” is not absolute and can be overcome by the immune system after a foreign stimuli caused by pathogens, allergens or other imknown immune errors (e.g., defects in apoptosis) that affect the immune system, causing a switch from tolerance to an immune response. Therefore作者: 淘氣 時(shí)間: 2025-3-27 15:20
DNA Vaccination against Autoimmune Diseases,ttenuation of pathogenic immune responses is a highly desirable end. Many forms of immunotherapy are being studied with these objectives in mind, but gene transfer approaches, and particularly DNA vaccination (transfer of an antigen gene), are promising. DNA vaccination is most often performed by no作者: 陶醉 時(shí)間: 2025-3-27 18:17
https://doi.org/10.1007/978-1-4757-5335-6Customs; USA; complexity; economy; hedging; logistics; regulation; science and technology
